| Age group | Total 45-69 | Total 50-69 | |||||
---|---|---|---|---|---|---|---|---|
 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 |  |  |
Number of women screened | 54,495 | 26,214 | 26,694 | 24,452 | 16,067 | 3,047 | 147,922 | 93,427 |
   Number of women with detected breast cancer | 169 | 126 | 150 | 245 | 211 | 46 | 901 | 732 |
Breast cancer detection rate | 3.1 | 4.8 | 5.6 | 10.0 | 13.1 | 15.1 | 6.1 | 7.8 |
   Number of women undergoing further assessment | 14,188 | 5,097 | 3,749 | 2,998 | 1,808 | 306 | 27,840 | 13,652 |
Further assessment rate | 26.0% | 19.4% | 14.0% | 12.3% | 11.3% | 10.0% | 18.8% | 14.6% |
   Number of women recalled for further assessment | 2,430 | 1,007 | 845 | 901 | 626 | 124 | 5,809 | 3,379 |
Recall rate | 4.5% | 3.8% | 3.2% | 3.7% | 3.9% | 4.1% | 3.9% | 3.6% |
   Women undergoing open biopsy - benign result | 35 | 18 | 8 | 14 | 11 | 1 | 86 | 51 |
   Women undergoing open biopsy - malignant result | 135 | 101 | 132 | 194 | 161 | 38 | 723 | 588 |
Benign to malignant open biopsy ratio | 0.26 | 0.18 | 0.06 | 0.07 | 0.07 | 0.03 | 0.12 | 0.09 |
Number of women with detected breast cancer (cases preceded by neoadjuvant therapy excluded) | 159 | 115 | 144 | 233 | 205 | 44 | 856 | 697 |
Advanced cases (TNM II+) | 47 | 34 | 45 | 72 | 55 | 19 | 253 | 206 |
Advanced cases proportion | 29.6% | 29.6% | 31.3% | 30.9% | 26.8% | 43.2% | 29.6% | 29.6% |
Invasive cases | 146 | 106 | 129 | 216 | 189 | 42 | 786 | 640 |
Invasive cases proportion | 91.8% | 92.2% | 89.6% | 92.7% | 92.2% | 95.5% | 91.8% | 91.8% |
Node-negative invasive cases | 83 | 68 | 85 | 136 | 124 | 24 | 496 | 413 |
Proportion among invasive | 56.8% | 64.2% | 65.9% | 63.0% | 65.6% | 57.1% | 63.1% | 64.5% |
Invasive ≤ 10 mm cases | 47 | 32 | 42 | 64 | 73 | 10 | 258 | 211 |
Proportion among invasive | 32.2% | 30.2% | 32.6% | 29.6% | 38.6% | 23.8% | 32.8% | 33.0% |